Intellectual Property
Jan. 18, 2007
Supreme Confusion
FOCUS COLUMN - By Rod S. Berman and Brian W. Kasell - The Supreme Court just spoke on a thorny procedural issue in patent litigation, making it easier to challenge patents.
By Rod S. Berman and Brian W. Kasell
In a much-watched case, the Supreme Court in MedImmune Inc. v. Genentech Inc., 2007 DJDAR 348 (Jan. 9), recently reversed the U.S. Court of Appeals for the Federal Circuit and held that a federal district court had subject-matter jurisdiction under the Declaratory Judgment Act to hear a suit brought by patent licensee MedImmune against...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In